MX342226B - Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio. - Google Patents

Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.

Info

Publication number
MX342226B
MX342226B MX2012011706A MX2012011706A MX342226B MX 342226 B MX342226 B MX 342226B MX 2012011706 A MX2012011706 A MX 2012011706A MX 2012011706 A MX2012011706 A MX 2012011706A MX 342226 B MX342226 B MX 342226B
Authority
MX
Mexico
Prior art keywords
treatment
streptococcus salivarius
respiratory tract
chronic infections
present
Prior art date
Application number
MX2012011706A
Other languages
English (en)
Other versions
MX2012011706A (es
Inventor
Stefani Stefania
Santagati Maria
Tiberi Licia
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Publication of MX2012011706A publication Critical patent/MX2012011706A/es
Publication of MX342226B publication Critical patent/MX342226B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a una nueva cepa microbiana de la especie Streptococcus salivarius para usarla en el tratamiento de procesos inflamatorios con o sin etiología infecciosa. Es otro objetivo de la presente invención las composiciones que comprenden dicha cepa, y sus usos.
MX2012011706A 2010-04-07 2011-04-07 Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio. MX342226B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM20100163 2010-04-07
PCT/IT2011/000104 WO2011125086A1 (en) 2010-04-07 2011-04-07 Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract

Publications (2)

Publication Number Publication Date
MX2012011706A MX2012011706A (es) 2013-03-08
MX342226B true MX342226B (es) 2016-09-21

Family

ID=42795606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012011706A MX342226B (es) 2010-04-07 2011-04-07 Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.

Country Status (18)

Country Link
US (1) US20130095044A1 (es)
EP (1) EP2555785B8 (es)
BR (1) BR112012025640A2 (es)
CA (1) CA2800514C (es)
CY (1) CY1117633T1 (es)
DK (1) DK2555785T3 (es)
ES (1) ES2573729T3 (es)
HR (1) HRP20160580T1 (es)
HU (1) HUE030227T2 (es)
IL (1) IL222333A (es)
ME (1) ME02448B (es)
MX (1) MX342226B (es)
PL (1) PL2555785T3 (es)
PT (1) PT2555785E (es)
RS (1) RS54837B1 (es)
SI (1) SI2555785T1 (es)
SM (2) SMP201200048B (es)
WO (1) WO2011125086A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10626294B2 (en) 2012-10-15 2020-04-21 L'oreal Aqueous wax dispersions containing volatile solvents
US10413496B2 (en) 2012-10-15 2019-09-17 L'oreal Aqueous wax dispersions
US9408785B2 (en) 2012-10-15 2016-08-09 L'oreal Hair styling compositions containing aqueous wax dispersions
US10561596B2 (en) 2014-04-11 2020-02-18 L'oreal Compositions and dispersions containing particles comprising a polymer
EP3015110A1 (en) 2014-10-28 2016-05-04 D.M.G. Italia Srl Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
PL3015109T3 (pl) 2014-10-28 2020-04-30 D.M.G. Italia Srl Bariera biologiczna z simetikonem do zastosowania w leczeniu zakażeń nosowo-gardłowo-przewodowych
CA3174212A1 (en) * 2020-04-03 2021-10-07 Blis Technologies Limited Antiviral treatment comprising blis containing probiotic products
CA3193157A1 (en) * 2020-09-04 2022-03-10 Universiteit Antwerpen A novel probiotic streptococcus salivarius strain and its uses
ES2973007A1 (es) * 2024-01-11 2024-06-17 Darwin Bioprospecting Excellence S L Probiotico oral
CN120098866B (zh) * 2025-05-09 2025-10-28 天津芯源生物科技有限公司 唾液链球菌嗜热亚种dy-001及其细菌素、冻干粉在治疗上呼吸道感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776462A (en) * 1996-12-10 1998-07-07 Sage R&D, A Partnership Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
ATE362481T1 (de) 1999-10-12 2007-06-15 Blis Technologies Ltd Lantibiotikum
CA2475310C (en) * 2002-02-22 2013-02-12 Blis Technologies Limited Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
WO2004072272A1 (en) 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions

Also Published As

Publication number Publication date
EP2555785B8 (en) 2016-07-13
IL222333A0 (en) 2012-12-31
IL222333A (en) 2017-02-28
RS54837B1 (sr) 2016-10-31
SI2555785T1 (sl) 2016-07-29
SMT201600190B (it) 2016-08-31
EP2555785A1 (en) 2013-02-13
SMP201200048B (it) 2013-07-09
CY1117633T1 (el) 2017-04-26
EP2555785B1 (en) 2016-04-06
MX2012011706A (es) 2013-03-08
DK2555785T3 (en) 2016-06-13
ES2573729T3 (es) 2016-06-09
BR112012025640A2 (pt) 2016-06-28
PL2555785T3 (pl) 2016-12-30
HRP20160580T1 (hr) 2016-06-17
CA2800514A1 (en) 2011-10-13
CA2800514C (en) 2019-06-18
SMAP201000048A (it) 2013-01-14
ME02448B (me) 2016-09-20
PT2555785E (pt) 2016-06-08
WO2011125086A1 (en) 2011-10-13
HUE030227T2 (en) 2017-05-29
US20130095044A1 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
MX342226B (es) Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.
MX2024009339A (es) Biomarcadores utiles en el diagnostico de infecciones bacterianas y virales.
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
WO2015014993A3 (en) Anti-infective compounds
MX376284B (es) Una composición que comprende un agente antibiótico y un agente dispersante o un agente antiadhesivo.
WO2014145958A3 (en) Network-based microbial compositions and methods
MX2009008617A (es) Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
WO2013184755A3 (en) Seca inhibitors and methods of making and using thereof
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
HRP20180972T1 (hr) Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija
WO2015003816A3 (en) Cystobactamides
MX2013000369A (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
EP2806731A4 (en) AGAINST DISEASE RESISTANT CITRUS COMPOSITIONS, ORGANISMS, SYSTEMS AND PROCEDURES
AU2008334326A8 (en) Recombinant bacteriophage for detection of nosocomial infection
WO2012019054A3 (en) Expression of antibody or a fragment thereof in lactobacillus
EP2570478A4 (en) REDUCTIONS OF MICRO-ORGANISMS OF BACILLUS GENUS AND APPLICATION THEREOF
IN2012DN01414A (es)
EP3059303A4 (en) Bacterial strain of actinoplanes sp. and application thereof
MX2014001572A (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.
HK1181319A (zh) 唾液链球菌在治疗慢性呼吸道感染中的应用
AU2018257122A1 (en) Pharmaceutical composition comprising attenuated streptococcus pneumoniae strains and use thereof
WO2013098413A3 (fr) Composition inhibitrice de croissance bactérienne et utilisation de cette composition
PL404948A1 (pl) Zastosowanie pinafide i chaetochromin

Legal Events

Date Code Title Description
FG Grant or registration